“We are thrilled that Dr. Rahadwa is joining the Shearwater team while the severity of the global nursing shortage continues,” said Tom Kendrot, chief executive officer, Shearwater Health. “Dr. Rahadwa’s significant experience and leadership within the provider market will be a valuable addition to the Shearwater team, allowing us to help reshape how nurses and clinicians are deployed within the healthcare space to achieve productivity and efficiency.”
Nashville-based Shearwater Health has trained and augmented care teams with remote and onsite clinicians since 1973, reducing the strain on the healthcare system. With a global workforce of more than 4,000 expertly trained, clinical resources supported by innovative technology and Six Sigma process excellence, Shearwater Health offers both remote and onsite clinical expertise that can be deployed rapidly and securely. The organization recruits and trains nurses in skills such as utilization management, care management, patient care, and revenue cycle and supports their careers through education including the US Nursing Licensure Exam.
Dr. Rahadwa echoed this sentiment, expressing her gratitude and excitement to join the Shearwater family. “I am truly honored and delighted to join Shearwater Health, a company renowned for its dedication to quality and innovation in the healthcare space. I look forward to working closely with Tom and other visionary leaders along with the amazing team towards improving healthcare outcomes, further propelling the organization to new heights!”
As Shearwater Health continues to carve out its place as a leader in the healthcare industry, the inclusion of Dr. Rahadwa is a testament to the company’s commitment to attracting the best talent to serve its mission.
The team at Shearwater Health warmly welcomes Dr. Rahadwa and is eager to witness the transformative contributions she is bound to make in her new role.
About Shearwater Health
Shearwater Health provides teams of remote and onsite clinicians that expand the size and impact of clinical teams so that clients can focus on internal teams practicing at the peak of their license. From bedside to back-office, there are over 4,000 Shearwater clinicians solving medical and administrative problems every hour of every day all over the world. Shearwater combines clinical expertise with Six Sigma process excellence and RPA technology to improve healthcare outcomes. For more information, please visithttps://shearwaterhealth.com/ or on Linked In
Media Contact
Heather Rivenburg, Punching Nun Group, 1 703-216-3893, [email protected], Punching Nun Group
FULTON, N.Y., Sept. 15, 2023 /PRNewswire/ — BNET offers emergency reentry, now with interoperability between CEAS jurisdictional programs. This allows essential employees to be recognized and given immediate access for post-disaster reentry. Adopting CEAS for Your Community New York City…
TCPA Staff Recognized with Medical Director of the Year and Quality Champion Awards
ATLANTA, Sept. 15, 2023 /PRNewswire-PRWeb/ — Today, TCPA, one of the largest provider groups in Georgia that partners with skilled nursing facilities and senior-living communities to deliver in-home care for elderly patients, announced its staff had received the Medical Director of the Year and Quality Champion Awards by the Georgia Medical Directors Association – The Society for Post-Acute and Long-Term Care Medicine (GMDA).
GMDA accepts nominations and gives these awards annually. The Medical Director of the Year Award is given to the Certified Medical Director who demonstrates exceptional leadership in the nursing centers that he or she serves while the Quality Champion award is given to the individual who is most committed to promoting quality care for long-term care residents.
This year, Dr. Amar Mohan, Founder and CEO of TCPA, was recognized as the Medical Director of the Year while Dawn Coffee, NP, was recognized as the Quality Champion of the Year. It marks the first time in GMDA’s history that both awards were given to members from the same organization.
“Congratulations to TCPA on this accomplishment,” said Perry Kemp, Executive Director of TCPA. “They have established systems that highlight areas of concern and areas of accomplishment in nursing home care. They maintain a high expectation of improvement continually from his centers and teach them how to improve.”
“We are incredibly honored to receive both the Georgia Medical Director of the Year Award and the Quality Champion Award from the Georgia Medical Directors Association,” said Amar Mohan, MD, Founder and CEO of TCPA. “These awards are a testament to the hard work, dedication, and unwavering commitment of our entire team. We remain steadfast in our mission to provide the highest quality healthcare services to our community.”
The Georgia Medical Directors Association (GMDA) is dedicated to advancing the practice of post-acute and long-term care medicine in Georgia. Each year, the GMDA recognizes outstanding individuals and organizations that have demonstrated exceptional leadership, innovation, and dedication to quality healthcare.
About TCPA
TCPApartners with leading skilled nursing facilities and assisted living facilities to improve healthcare transitions and long-term care. TCPA’s unique, team-based care model complements primary care, maximizes care coordination, and enables early identification and response to healthcare risks. Our approach improves clinical outcomes, reduces healthcare costs, and enables our providers to develop meaningful personal relationships with their patients and focus on proactive, whole-person care. For more information, please visit http://www.tcpamd.com.
DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Aortic Aneurysm Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global aortic aneurysm market is poised for robust growth, with projected revenues surging from $3.15 billion in 2022 to $3.41 billion in…
“The FDA heard courageous testimony about the toll this disease takes on patients, about the need for improved diagnostic and screening processes, and about the lengths caregivers are going to support the health of their loved ones. Above all, they heard about the urgent need for an approved treatment. Families are doing everything they can with the resources at their disposal, but this is a devastatingly progressive disease. As we work together to make an approved PDCD treatment a reality, it’s vital the process reflects that urgency,” said UMDF President and Chief Executive Officer Brian Harman.
“We thank the FDA for the opportunity to help their staff understand the PDCD community’s experiences and perspectives. It’s crucial that we continue to lift up the voices of expertise – patients, families, clinicians, and researchers – in forums like this,” he added.
Said MitoAction Chief Executive Officer Kira Mann: “As the patient-centered patient advocacy organization, we stand committed to fostering a space where the voices of those affected by mitochondrial diseases like PCDC can resonate. Just as we are dedicated to amplifying these voices, we also acknowledge the paramount significance of empowering patients and caregivers with knowledge about the FDA regulatory process. As advocates, we aim to empower individuals with the tools they need to actively engage in this critical process and ensure their voices are heard, because when patients are informed and engaged, they become a driving force for progress.”
UMDF and MitoAction thank the PDCD community members who bravely shared their stories and the many patient advocacy groups that helped make the listening session a success including Hope for PDCD and The Elizabeth Watt PDCD Research Fund.
Six caregivers to PDCD patients (one of whom is also an affected adult) participated in the FDA videoconference, along with clinician Rebecca Ganetzky, MD, of Children’s Hospital of Philadelphia.
Amongst the testimony heard was Emma, whose daughter Elizabeth is a 20-year-old patient with PDCD.
“As a family, we have lived in a crisis mode for the past 20 years. Constantly worried about death. We have already watched her regress medically and physically, and we fear that every illness will be the one that ends her life. Even minor illnesses can be catastrophic, so we live all day every day in fear. The sad fact is there is not a definitive treatment for PDCD,” she said. “Collectively, we come here today to ask for the hope that all people diagnosed with PDCD will be able to live a long and fulfilling life.”
This was the second FDA Listening Session UMDF and MitoAction have cohosted for a mitochondrial disease in the last 20 months. In January 2022, the FDA held a similar session for thymidine kinase 2 deficiency (TK2d), another rare mitochondrial disease.
ABOUT PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
Pyruvate Dehydrogenase Complex Deficiency (PDCD) is a rare mitochondrial disorder that causes impaired carbohydrate metabolism, resulting in neurological problems and a buildup of a chemical called lactic acid in the blood. PDCD is caused by mutations in the genes that make up or affect the activity of the PDC, which is located in the mitochondria that make almost all the energy we need to survive. Nearly all individuals with PDCD experience developmental delay, poor muscle tone, and brain cell loss, which are often accompanied by a host of other issues. Like all mitochondrial diseases, there is currently no FDA-approved treatment or cure for PDCD.
ABOUT THE UNITED MITOCHONDRIAL DISEASE FOUNDATION
Founded in 1996, the United Mitochondrial Disease Foundation (UMDF) works to promote research and education for the diagnosis, treatment and cure of mitochondrial diseases and to provide support for affected individuals and families. Since its inception, the UMDF has funded more than $15 million in research, making it the leading non-governmental contributor of grants focused solely on mitochondrial disease. Every year, UMDF provides support and education to thousands of patients and medical professionals across the globe. Learn more at umdf.org.
ABOUT MITOACTION
Since 2005, MitoAction has transformed the lives of families affected by mitochondrial disease. Our mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives, and granting wishes for children affected by mitochondrial disease. Committed to making the largest impact possible, MitoAction serves individuals in the U.S. and worldwide through support, education, outreach, advocacy, and clinical research initiatives. The programs and services MitoAction provides continue to be a lifeline for families impacted by mitochondrial disease. Families know with MitoAction, they will never be alone on this difficult journey. Learn more at mitoaction.org.
LONDON, Sept. 15, 2023 /PRNewswire/ — Yermek Alimov, a prominent Kazakh businessman, has issued a claim against Abdumalik Mirakhmedov, Rashit Makhat, Andrey Kim (collectively known as MMK) and Genesis Digital Assets Limited in the High Court of England and Wales. The claim relates to…
In fact, most energy companies aren’t positioned to objectively analyze and solve these types of issues without risking costly disruptions to their businesses. That’s why Cyclotron Group is pleased to announce a new initiative for providing vertical-specific solutioning for energy sector companies.
“The energy sector is a very complex vertical, which makes solving business process and workflow issues difficult. It’s important to have an objective vantage point for assessing problems and a flexible toolset that’s up to the challenge,” says Amber Bahl, CEO of Cyclotron Group. “Microsoft 365 really does offer the best platform available to address these issues. The M365 toolset is best-in-class when it comes to improving and maintaining the long-term health of companies in the energy sector.”
Some of the challenges facing modern energy companies include:
Challenge: Costly lags in tracking capital costs, which can result in unforeseen financial consequences. Solution: Implement automation in financial updates that allow for single-click approvals and automatic pricing updates.
Challenge: Disparate financial and resource management systems that don’t communicate with each other. Solution: Implement cloud-based Microsoft Defender protection that integrates with disconnected environments via proxy architecture with carefully controlled cloud security connection points to protect against cybersecurity threats.
Challenge: Remove business process bottlenecks caused legacy technology and disparate platforms and applications. Solution: Implement Microsoft Teams with Contact Center as the management platform for communications, reporting, monitoring, and staff management.
Challenge: Simplify complicated data management processes and enable real-time insights into production, supply chain, and sales data. Solution: Implement Azure Synapse Analytics to unify big data and data warehousing into a single, powerful service that provides real-time analytics at a massive scale.
Challenge: Remedy the lack of insight into capital equipment. Solution: Implement an Azure IoT Hub that allows for bidirectional communication and the ability to monitor, manage, and analyze equipment and performance in real time.
Challenge: Inefficient application development and deployment and a lack of collaboration among development teams. Solution: Implement Azure DevOps to support collaborative application development, from source code management to deployment and monitoring.
Challenge: Ensure frontline workers and back-office information workers are working with the same, up-to-date data. Solutions: Implement best practices for M365 tools that improve collaboration and awareness among frontline and back-office workers.
Challenge: Inefficient or broken workflows caused by inadequate or substandard implementation of MS Dynamics 365 tools and solutions. Solution: Cyclotron provides dedicated support for Dynamics 365 modules and can address specific issues encountered by organizations in integrating Dynamics 365 with their other Microsoft collaboration tools.
“There are a lot of factors that contribute to workflow and business process challenges, but without solid change leadership to marshal improvements, organizations risk creating additional new problems. That’s why change management is a primary focus of Cyclotron in every client engagement. We understand the impacts of every choice made and work to steer energy companies towards actions that promote long-term organizational health,” adds Mr. Bahl.
To ask a question or to learn more about Cyclotron’s solutions for manufacturing organizations and hear some of our success stories, please reach out to us at [email protected].
From its inception, the organization has aimed to redefine mental health care standards by ensuring that every student-athlete receives the support they deserve. Taking a proactive approach, CBHA bridges the gap created by the stigma and hesitations often associated with seeking mental health assistance ensuring that every licensed professional has the necessary time to work with athletes that can lead to proper, long-term solutions.
Steve Wigginton, the Chief Executive Officer of CBHA, added to the company’s vision of being one of the top 5 mental health providers in the world by providing care to 100,000 to 200,000 patients per year. “We recognize the urgent need for change in the mental health care landscape,” Wigginton stated, “and we are dedicated to making that change happen. While our current priority is supporting athletes, our long-term vision includes expanding our services to reach the entire student body and all other entities in need of comprehensive mental health care within the United States. This is the transformation mental health care needs in this country.”
CBHA’s groundbreaking efforts are paving the way for a brighter future where mental health care is accessible, comprehensive, and compassionate, starting with college athletes.
“People who experience mental illness and substance use disorders must receive the support they need when they need it,” Dr. Sizer said. “We know that behavioral health is essential to overall regional primary and population health outcomes. We also know that prevention works, treatment is effective, and people recover.”
“Our Recovery Day Celebration is specifically designed to encourage health-seeking behaviors and to build unity around what can unite us,” Dr. Sizer said. “This is why we continue to include our Arts as Medicine and related creative initiatives in the work we do. We must unify and thrive around the complex challenges we mutually face.”
The Recovery Day Celebration highlights and celebrates people in recovery from substance use and mental disorders, along with treatment providers promoting that recovery is possible in all forms. This day of celebration, within Recovery Month, is part of a national observance that promotes the societal benefits of prevention, treatment, and recovery. The event will feature speakers with lived experiences, NARCAN Training, health and wellness activities, interactive games and crafts, food, and music provided by SNAZZ Band.
NEDHSA’s Opioid Use Disorder Prevention Manager Kara J. Etienne, LMSW, said, “NEDHSA’s Recovery Day Celebration is not only for people in recovery but has been designed with the contributions of treatment and service providers in mind, and will also be a day for them to “celebrate” their contributions.”
“The day has been planned as a fun-filled, relaxing day that will bring together various agencies within NEDHSA’s catchment area and from other areas of the state to share resources and messages that will strengthen and renew hope, all while interacting through music, crafts, and games,” Etienne said.
Prevent Blindness is also debuting a new episode in the online Focus on Eye Health Expert Series, “Uveitis and Inflammatory Eye Diseases.” Jeff Todd, president and CEO of Prevent Blindness, interviews Steven Yeh, MD, Professor and Stanley Truhlsen Jr. Chair of Ophthalmology, Truhlsen Eye Institute, University of Nebraska Medical Center. Dr. Yeh is also a volunteer on the Prevent Blindness Scientific Committee.
The uvea is a layer of the eye made up of three parts from the front to the back of the eye that helps provide nutrients to the eye. Uveitis is a term used to describe a group of inflammatory diseases or inflammation of the eye, which can be serious and lead to permanent vision loss. Uveitis causes about 30,000 new cases of blindness each year in the United States.
Signs and symptoms of uveitis include:
Eye redness
Eye pain
Light sensitivity
Blurred vision
Dark, floating spots in your field of vision (floaters)
Decreased vision
In addition to uveitis, there are many other types of IED. To help explain, Prevent Blindness offers the “Inflammatory Eye Disease” episode of the Focus on Eye Health Expert Series. This episode features Ann-Marie Lobo-Chan, MD, MS, of the Illinois Eye and Ear Infirmary, Associate Professor of Ophthalmology, Co-Director, Uveitis Service, University of Illinois College of Medicine, Department of Ophthalmology, and patient Addison Schwaller, Emergency Medicine Physician Assistant at Logansport Memorial Hospital in Logansport, Ind.
“Although ‘Inflammatory Eye Disease’ may not be a term that most people are familiar with, it is a condition that can have severe impact on vision if left untreated,” said Todd. “We encourage people to educate themselves on the various types of IEDs and whether they are at risk for, or have developed them already, to help prevent unnecessary vision loss.”
About Prevent Blindness Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.
